| Ayoku S Oketunji, MD | |
|
301 Hospital Dr, Glen Burnie, MD 21061-5803 | |
| (410) 787-4000 | |
| Not Available |
| Full Name | Ayoku S Oketunji |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 46 Years |
| Location | 301 Hospital Dr, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083697312 | NPI | - | NPPES |
| 201781400 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0043977 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mdics At Bwmc Llc | 7315106184 | 63 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
| Entity Name | Northwest Hospital Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508961988 PECOS PAC ID: 6204739352 Enrollment ID: O20040128000328 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
| Entity Name | Baltimore Washington Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124016696 PECOS PAC ID: 7719879485 Enrollment ID: O20040326001160 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
| Entity Name | Mdics At Bwmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306131578 PECOS PAC ID: 7315106184 Enrollment ID: O20120314000455 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayoku S Oketunji, MD 300 Hospital Dr, St 215, Glen Burnie, MD 21061-6902 Ph: (410) 787-4897 | Ayoku S Oketunji, MD 301 Hospital Dr, Glen Burnie, MD 21061-5803 Ph: (410) 787-4000 |
News Archive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
A virtual special session of the annual Legionella Conference co-hosted by NSF Health Sciences and the National Environmental Health Association (NEHA) will focus on disease prevention from waterborne pathogens during a public health crisis.
› Verified 3 days ago
Mrs. Salvacion Dupaya Ramirez, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 7845 Oakwood Rd, Ste 307, Glen Burnie, MD 21061 Phone: 410-760-4888 Fax: 410-760-1870 | |
Anuradha Boddeti, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 808 Landmark Dr, Suite 122, Glen Burnie, MD 21061 Phone: 410-760-3588 Fax: 410-760-3604 | |
Dr. Gurmeet Singh Sawhney, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 Hospital Dr, 202, Glen Burnie, MD 21061 Phone: 410-766-7616 Fax: 410-766-3092 | |
Mirza M. Nusairee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Madison Park Dr, Suite #100, Glen Burnie, MD 21061 Phone: 410-766-4747 Fax: 410-766-4855 | |
Ijemma Chinomnso Cunningham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6934 Aviation Blvd Ste F, Glen Burnie, MD 21061 Phone: 410-760-3588 Fax: 410-760-3604 | |
Dr. Deep H Dalal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1406b Crain Hwy S, Suite 207, Glen Burnie, MD 21061 Phone: 410-590-4730 Fax: 410-590-4737 | |
Sridhar Atluri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7310 Ritchie Hwy, Suite 800, Glen Burnie, MD 21061 Phone: 410-768-3936 Fax: 410-766-6683 |